Sunzen Biotech Bhd | Cash Flow
Fiscal year is January-December. All values MYR Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
4,089.80
1,391.40
286.70
454.90
4,012.40
Depreciation, Depletion & Amortization
785.60
730.00
1,051.10
959.20
989.10
Other Funds
7.30
8.80
4.00
2,779.10
-
Funds from Operations
4,354.10
2,715.30
119.10
1,049.80
4,684.60
Changes in Working Capital
2,364.90
1,356.80
5,164.10
106.10
190.80
Net Operating Cash Flow
1,989.20
4,072.10
5,283.20
1,155.90
4,875.40
Capital Expenditures
189.70
249.30
4,821.60
6,635.90
3,417.00
Sale of Fixed Assets & Businesses
158.60
-
230.80
3,468.00
0.00
Net Investing Cash Flow
31.10
249.30
4,590.80
3,167.90
3,417.00
Cash Dividends Paid - Total
895.90
1,194.20
-
-
1,444.90
Issuance/Reduction of Debt, Net
660.60
658.40
729.30
2,293.00
3,198.90
Net Financing Cash Flow
1,551.50
3,386.00
2,657.40
44,506.90
4,324.30
Net Change in Cash
391.80
7,277.90
7,143.50
42,457.10
3,152.50
Free Cash Flow
1,799.60
3,822.80
10,104.80
5,480.00
1,458.40
Change in Capital Stock
2.30
5,247.40
3,382.70
44,020.70
319.40
Exchange Rate Effect
14.80
69.10
73.20
37.70
286.70
About Sunzen Biotech Bhd
View Profile
